• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS PED.W/SA 15 A.PRECHAMBER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS PED.W/SA 15 A.PRECHAMBER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV440-T
Device Problem Reset Problem (3019)
Patient Problem Hydrocephalus (3272)
Event Date 03/02/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Patient data - height 140 cm.Reported device not marketed in the u.S., however, similar devices or devices that share components, raw materials, process methods or other technological characteristics are registered within the u.S.K161853.Manufacturing site evaluation: investigation on-going.Additional information/investigation results will be provided in a supplemental report.
 
Event Description
It was reported that a progav valve was not adjusting.A patient underwent a shunt system implantation on (b)(6) 2019 and the initial pressure was set to 20cm h2o.On (b)(6) 2019, during the initial reset, the pressure was not able to be adjusted.All available pressure-regulating tools were used in an attempt to change it.On (b)(6) 2019, the shunt was replaced due to this malfunction.It was noted that the original valve was then tested after removal and required 7-8 attempts in order to successfully make an adjustment.Further details are not available.
 
Manufacturer Narrative
Manufacturing evaluation: the shunt system was received dry (not submersed in liquid as suggested).The shunt assistant was not returned; due to the reason for the complaint, only the progav valve has been investigated in the scope of this report.Visual inspection - a deformation of the outer housing of the progav valve was observed through the visual inspection.The valve housing was subsequently measured and confirmed the presence of a deformation.The housing deformation measured at 0.040 mm, outside the tolerance range.Permeability- testing indicated that the valve has a blockage.Adjustment - the test showed it was adjustable to all specified pressures.Braking force/function - the test showed that the brake function operated as expected.However, the breaking force required was not within the specified tolerances.Results - it should be noted that the valve was received dry.The investigation of dry items is not significant due to the affect dry deposits of liquor and blood can have on product performance.In spite of this, we have investigated the valve to the best of our abilities.The valve was not permeable, but was easily adjustable to all pressure setting.The braking force was lower than expected, confirming the valve's easy adjustability.Based on our investigation, we are unable to substantiate the claim of non-adjustability.However, ti is possible that the observed deformation could have compromised the system and could be responsible for the suspected malfunction in the past.The cause of the deformation of the valve and the resultant compromise of the system could not be determined through our investigation.Significant outside pressure, for example by too much force from the adjustment tool or by a fall or impact to the head of the patient, can compromise the integrity of the valve.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV SYS PED.W/SA 15 A.PRECHAMBER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam, 14469
GM  14469
MDR Report Key8484858
MDR Text Key140971560
Report Number3004721439-2019-00100
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
SEE H10
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/06/2022
Device Model NumberFV440-T
Device Catalogue NumberFV440-T
Device Lot Number20033276
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/18/2019
Distributor Facility Aware Date04/11/2019
Device Age23 MO
Initial Date Manufacturer Received 03/05/2019
Initial Date FDA Received04/04/2019
Supplement Dates Manufacturer Received04/11/2019
Supplement Dates FDA Received05/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age8 YR
Patient Weight36
-
-